Your browser doesn't support javascript.
loading
Periplocymarin alleviates pathological cardiac hypertrophy via inhibiting the JAK2/STAT3 signalling pathway.
Fan, Cai-Lian; Liang, Sui; Ye, Meng-Nan; Cai, Wan-Jun; Chen, Miao; Hou, Yun-Long; Guo, Jun; Dai, Yi.
Affiliation
  • Fan CL; Department of Cardiology, Jinan University First Affiliated Hospital, Jinan University, Guangzhou, China.
  • Liang S; Department of Cardiology, Jinan University First Affiliated Hospital, Jinan University, Guangzhou, China.
  • Ye MN; College of Pharmacy, Jinan University, Guangzhou, China.
  • Cai WJ; College of Pharmacy, Jinan University, Guangzhou, China.
  • Chen M; College of Pharmacy, Jinan University, Guangzhou, China.
  • Hou YL; National Key Laboratory of Collateral Disease Research and Innovative Chinese Medicine, Shijiazhuang, China.
  • Guo J; Department of Cardiology, Jinan University First Affiliated Hospital, Jinan University, Guangzhou, China.
  • Dai Y; College of Pharmacy, Jinan University, Guangzhou, China.
J Cell Mol Med ; 26(9): 2607-2619, 2022 05.
Article in En | MEDLINE | ID: mdl-35365949
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiac Glycosides / Heart Failure Type of study: Prognostic_studies / Risk_factors_studies Limits: Animals Language: En Journal: J Cell Mol Med Journal subject: BIOLOGIA MOLECULAR Year: 2022 Type: Article Affiliation country: China
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiac Glycosides / Heart Failure Type of study: Prognostic_studies / Risk_factors_studies Limits: Animals Language: En Journal: J Cell Mol Med Journal subject: BIOLOGIA MOLECULAR Year: 2022 Type: Article Affiliation country: China